Akribion

A new class of cancer therapies using RNA-guided nucleases for specific cell depletion

Total raised

€8.0M

€8,000,000

Funding rounds

Investors

distinct backers

Active since

2025-02

latest 2025-02

Funding by year

EUR raised per year

High confidence

Raise-next likelihood48

base rate 44% for Seed

Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

1 rounds

Date	Stage	Amount	Investors
2025-02-04	Seed	€8.0M	Carma Fund,Bruker Invest,Hessen Kapital I,High-Tech Gründerfonds (HTGF),MP Beteiligungs GmbH,RV Invest	View deal →

same sector or country